Feasibility and Safety of Immunoglobulin (Ig) Treatment in COPD Outpatients With Frequent Exacerbations: Pilot Study 1

Clinical trial NCT03018652 · COMPLETED

Trial details

NCT number: NCT03018652
Sponsor: Ottawa Hospital Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2018-03-11
Primary completion: 2019-11-20
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.